Regulation of vascular smooth muscle cell differentiation

Journal of Vascular Surgery

Volumn 45, Issue 6 SUPPL., 2007, Pages A25-A32

  Rzucidlo, Eva M ^a   Martin, Kathleen A ^a   Powell, Richard J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; S6 KINASE;

ANEURYSM; ARTERY INTIMA PROLIFERATION; ARTICLE; ASTHMA; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL INTERACTION; HUMAN; HYPERTENSION; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RESTENOSIS; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 34249307295     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.03.001     Document Type: Article

References (63)

1. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75 (1995) 487-517
2. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84 (2004) 767-801
3. Sobue K., Hayashi K., and Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 190 (1999) 105-118
4. Au Y.P., Kenagy R.D., Clowes M.M., and Clowes A.W. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis 23 suppl 1 (1993) 177-182
5. Karnovsky M.J., Wright Jr. T.C., Castellot Jr. J.J., Choay J., Lormeau J.C., and Petitou M. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis. Ann N Y Acad Sci 556 (1989) 268-281
6. Orlandi A., Ropraz P., and Gabbiani G. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin. Exp Cell Res 214 (1994) 528-536
7. Cook C.L., Weiser M.C., Schwartz P.E., Jones C.L., and Majack R.A. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res 74 (1994) 189-196
8. Owens G.K., and Thompson M.M. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. J Biol Chem 261 (1986) 13373-13380
9. O'Brien E.R., Alpers C.E., Stewart D.K., Ferguson M., Tran N., Gordon D., et al. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 73 (1993) 223-231
10. Wilcox J.N. Analysis of local gene expression in human atherosclerotic plaques. J Vasc Surg 15 (1992) 913-916
11. Clowes A.W., Reidy M.A., and Clowes M. Mechanisms of stenosis after arterial injury. Lab Invest 49 (1983) 208-215
12. Newby A.C., and Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J Pathol 190 (2000) 300-309
13. Marx S.O., and Marks A.R. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 104 (2001) 852-855
14. Shah P.K., Falk E., Badimon J.J., Fernandez-Ortiz A., Mailhac A., Villareal-Levy G., et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92 (1995) 1565-1569
15. Folkman J., and D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 87 (1996) 1153-1155
16. Hirschi K.K., Rohovsky S.A., and D'Amore P. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141 (1998) 805-814
17. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
18. Heilmann C., Beyersdorf F., and Lutter G. Collateral growth: cells arrive at the construction site. Cardiovasc Surg 10 (2002) 570-578
19. Powell R.J., Bhargava J., Basson M.D., and Sumpio B.E. Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology. Am J Physiol 274 (1998) H642-H649
20. Powell R.J., Cronenwett J.L., Fillinger M.F., Wagner R.J., and Sampson L.N. Endothelial cell modulation of smooth muscle cell morphology and organizational growth pattern. Ann Vasc Surg 10 (1996) 4-10
21. Powell R.J., Hydowski J., Frank O., Bhargava J., and Sumpio B.E. Endothelial cell effect on smooth muscle cell collagen synthesis. J Surg Res 69 (1997) 113-118
22. Powell R.J., and Sumpio B.E. Regulation of smooth muscle cell differentiation and expression of nonmuscle myosin by endothelial cells in coculture. Surg Forum (1997) 408-410
23. Fingerle J., Au Y.P., Clowes A.W., and Reidy M.A. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 10 (1990) 1082-1087
24. Nugent H.M., and Edelman E.R. Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. J Surg Res 99 (2001) 228-234
25. Zilla P. Endothelialization of vascular grafts. Curr Opin Cardiol 6 (1991) 877-886
26. Boerth N.J., Dey N.B., Cornwell T.L., and Lincoln T.M. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34 (1997) 245-259
27. Brophy C.M., Woodrum D.A., Pollock J., Dickinson M., Komalavilas P., Cornwell T.L., et al. cGMP-dependent protein kinase expression restores contractile function in cultured vascular smooth muscle cells. J Vasc Res 39 (2002) 95-103
28. Reusch H.P., Schaefer M., Plum C., Schultz G., and Paul M. Gbeta gamma mediate differentiation of vascular smooth muscle cells. J Biol Chem 276 (2001) 19540-19547
29. Hayashi K., Takahashi M., Kimura K., Nishida W., Saga H., and Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (AKT) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 145 (1999) 727-740
30. Ohkawa Y., Hayashi K., and Sobue K. Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells. Biochem Biophys Res Commun 301 (2003) 78-83
31. Mano T., Luo Z., Malendowicz S.L., Evans T., and Walsh K. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ Res 84 (1999) 647-654
32. Morrisey E.E. GATA-6: the proliferation stops here: cell proliferation in glomerular mesangial and vascular smooth muscle cells. Circ Res 87 (2000) 638-640
33. Perlman H., Suzuki E., Simonson M., Smith R.C., and Walsh K. GATA-6 induces p21(Cip1) expression and G1 cell cycle arrest. J Biol Chem 273 (1998) 13713-13718
34. Kakita T., Hasegawa K., Morimoto T., Kaburagi S., Wada H., and Sasayama S. p300 protein as a coactivator of GATA-5 in the transcription of cardiac-restricted atrial natriuretic factor gene. J Biol Chem 274 (1999) 34096-34102
35. Obata H., Hayashi K., Nishida W., Momiyama T., Uchida A., Ochi T., et al. Smooth muscle cell phenotype-dependent transcriptional regulation of the alpha1 integrin gene. J Biol Chem 272 (1997) 26643-26651
36. Nishida W., Nakamura M., Mori S., Takahashi M., Ohkawa Y., Tadokoro S., et al. A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes. J Biol Chem 277 (2002) 7308-7317
37. Wada H., Hasegawa K., Morimoto T., Kakita T., Yanazume T., and Sasayama S. A p300 protein as a coactivator of GATA-6 in the transcription of the smooth muscle-myosin heavy chain gene. J Biol Chem 275 (2000) 25330-25335
38. Pipes G.C., Creemers E.E., and Olson E. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20 (2006) 1545-1556
39. Gingras A.C., Raught B., and Sonenberg N. mTOR signaling to translation. Curr Top Microbiol Immunol 279 (2004) 169-197
40. Podbielski J., and Schoenberg L. Use of sirolimus in kidney transplantation. Prog Transplant 11 (2001) 29-32
41. Eisenberg M.J., and Konnyu K.J. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol 98 (2006) 375-382
42. Moliterno D.J. Healing Achilles--sirolimus versus paclitaxel. N Engl J Med 353 (2005) 724-727
43. Poon M., Marx S.O., Gallo R., Badimon J.J., Taubman M.B., and Marks A.R. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98 (1996) 2277-2283
44. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
45. Martin K.A., Rzucidlo E.M., Merenick B.L., Fingar D.C., Brown D.J., Wagner R.J., et al. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol 286 (2004) C507-C517
46. Jacinto E., and Hall M.N. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol 4 (2003) 117-126
47. Kanayasu-Toyoda T., Yamaguchi T., Uchida E., and Hayakawa T. Commitment of neutrophilic differentiation and proliferation of HL-60 cells coincides with expression of transferrin receptor. Effect of granulocyte colony stimulating factor on differentiation and proliferation. J Biol Chem 274 (1999) 25471-25480
48. Yamamoto-Yamaguchi Y., Okabe-Kado J., Kasukabe T., and Honma Y. Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors. Exp Hematol 29 (2001) 582-588
49. Gagnon A., Lau S., and Sorisky A. Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion. J Cell Physiol 189 (2001) 14-22
50. Oh C.D., Kim S.J., Ju J.W., Song W.K., Kim J.H., Yoo Y.J., et al. Immunosuppressant rapamycin inhibits protein kinase C alpha and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis. Eur J Pharmacol 427 (2001) 175-185
51. Braun-Dullaeus R.C., Mann M.J., Seay U., Zhang L., von Der Leyen H.E., Morris R.E., et al. Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol 21 (2001) 1152-1158
52. Martin K.A., and Blenis J. Coordinate regulation of translation by the PI 3-kinase and mTOR pathways. Adv Cancer Res 86 (2002) 1-39
53. Sarbassov D.D., Ali S.M., and Sabatini D. Growing roles for the mTOR pathway. Curr Opin Cell Biol 17 (2005) 596-603
54. Harrington L.S., Findlay G.M., and Lamb R. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 30 (2005) 35-42
55. Tremblay F., and Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 276 (2001) 38052-38060
56. Tremblay F., Krebs M., Dombrowski L., Brehm A., Bernroider E., Roth E., et al. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54 (2005) 2674-2684
57. Um S.H., D'Alessio D., and Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3 (2006) 393-402
58. Greene M.W., and Garofalo R.S. Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation. Biochemistry 41 (2002) 7082-7091
59. Brown D.J., Rzucidlo E.M., Merenick B.L., Wagner R.J., Martin K.A., and Powell R.J. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/AKT pathway promotes differentiation. J Vasc Surg 41 (2005) 509-516
60. Fillinger M.F., Sampson L.N., Cronenwett J.L., Powell R.J., and Wagner R.J. Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J Surg Res 67 (1997) 169-178
61. Di Luozzo G., Bhargava J., and Powell R. Vascular smooth muscle cell effect on endothelial cell endothelin-1 production. J Vasc Surg 31 (2000) 781-789
62. Vane J., and Corin R.E. Prostacyclin: a vascular mediator. Eur J Vasc Endovasc Surg 26 (2003) 571-578
63. Fetalvero K.M., Shyu M., Nomikos A.P., Chiu Y.F., Wagner R.J., Powell R.J., et al. The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway. Am J Physiol Heart Circ Physiol 290 (2006) H1337-H1346